Carna Biosciences Cancels Deal With Janssen Biotech Due to Strategy Reasons

* Announces cancellation of licensing agreement with Janssen Biotech, Inc. due to strategy reason

* Says all the rights of development and sales from Janssen Biotech, Inc. will be returned

* Says effective on Aug. 23
MORE ON THIS TOPIC